When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - Subcutaneous version of J&J's Darzalex OK'd in Canada
Johnson & Johnson
Health Canada has approved a subcutaneous formulation of Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical Companies' multiple myeloma med Darzalex (daratumumab), originally approved for intravenous administration.
More news on: Johnson & Johnson, Genmab A/S, Halozyme Therapeutics, Inc., Healthcare stocks news,